Hypocholesterolemic and prebiotic effects of a whole-grain oat-based granola breakfast cereal in a cardio-metabolic "at risk" population

Frontiers in Microbiology

Volumn 7, Issue NOV, 2016, Pages

  Connolly, Michael L ^a   Tzounis, Xenofon ^a   Tuohy, Kieran M ^a,b   Lovegrove, Julie A ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b RESEARCH AND INNOVATION CENTRE   (Italy)

Author keywords

Bifidobacterium; Cardiovascular risk; Cholesterol; Prebiotic; Whole grain oat granola

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREBIOTIC AGENT; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; BLOATING; BLOOD SAMPLING; CARDIOMETABOLIC RISK; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOUBLE BLIND PROCEDURE; ENERGY METABOLISM; FECES MICROFLORA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD COMPOSITION; FOOD INTAKE; GASTROINTESTINAL DISEASE; GLUCOSE INTOLERANCE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTESTINE FLORA; MALE; METABOLIC DISORDER; OAT; RANDOMIZED CONTROLLED TRIAL; WHOLE GRAIN; WHOLE GRAIN OAT GRANOLA;

EID: 85006750971     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01675     Document Type: Article

References (47)

1. Andersson, K. E., Axling, U., Xu, J., Swärd, K., Ahrné, S., Molin, G., et al. (2013). Diverse effects of oats on cholesterol metabolism in C57BL/6 mice correlate with expression of hepatic bile acid-producing enzymes. Eur. J. Nutr. 52, 1755-1769. doi: 10.1007/s00394-012-0479-1.
2. Begley, M., Hill, C., and Gahan, C. G. (2006). Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 72, 1729-1738. doi: 10.1128/AEM.72.3.1729-1738.2006.
3. Beylot, M. (2005). Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br. J. Nutr. 93(Suppl. 1), S163-S168. doi: 10.1079/BJN20041339.
4. Borneo, R., and León, A. E. (2012). Whole grain cereals: functional components and health benefits. Food Funct. 3, 110-119. doi: 10.1039/C1FO10165J.
5. Borthakur, A., Priyamvada, S., Kumar, A., Natarajan, A. A., Gill, R. K., Alrefai, W. A., et al. (2012). A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am. J. Physiol. Gastrointest. Liver Physiol. 303, 1126-1133. doi: 10.1152/ajpgi.00308.2012.
6. Carvalho-Wells, A. L., Helmolz, K., Nodet, C., Molzer, C., Leonard, C., McKevith, B., et al. (2010). Determination of the in vivo prebiotic potential of a maize-based whole grain breakfast cereal: a human feeding study. Br. J. Nutr. 104, 1353-1356. doi: 10.1017/S0007114510002084.
7. Charlton, K. E., Tapsell, L. C., Batterham, M. J., O'Shea, J., Thorne, R., Beck, E., et al. (2012). Effect of 6 weeks' consumption of β-glucan-rich oat products on cholesterol levels in mildly hypercholesterolaemic overweight adults. Br. J. Nutr. 107, 1037-1047. doi: 10.1017/S0007114511003850.
8. Chatenoud, L., Tavani, A., La Vecchia, C., Jacobs, D. R., Negri, E., Levi, F., et al. (1998). Whole grain food intake and cancer risk. Int. J. Cancer 77, 24-28.
9. Connolly, M. L., Lovegrove, J. A., and Tuohy, K. M. (2010). In vitro evaluation of the microbiota modulation abilities of different sized whole oat grain flakes. Anaerobe 16, 483-488. doi: 10.1016/j.anaerobe.2010.07.001.
10. Connolly, M. L., Tuohy, K. M., and Lovegrove, J. A. (2012). Wholegrain oat-based cereals have prebiotic potential and low glycaemic index. Br. J. Nutr. 108, 2198-2206. doi: 10.1017/S0007114512000281.
11. Costabile, A., Klinder, A., Fava, F., Napolitano, A., Fogliano, V., Leonard, C., et al. (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br. J. Nutr. 99, 110-120. doi: 10.1017/S0007114507793923.
12. Daims, H., Stoecker, K., and Wagner, M. (2005). "Fluorescence in situ hybridization for the detection of prokaryotes" in Molecular Microbial Ecology, eds M. Osborn and C. Smith (New York, NY: Taylor & Francis), 192-201.
13. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2010). Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006. EFSA J. 8:1885. doi: 10.2903/j.efsa.2010.1885.
14. Ejtahed, H. S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., et al. (2011). Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. J. Dairy Sci. 94, 3288-3294. doi: 10.3168/jds.2010-4128.
15. Franks, A. H., Harmsen, H. J., Raangs, G. C., Jansen, G. J., Schut, F., and Welling, G. W. (1998). Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl. Environ. Microbiol. 64, 3336-3345.
16. Gunness, P., and Gidley, M. J. (2010). Mechanisms underlying the cholesterol-lowering properties of soluble dietary fiber polysaccharides. Food Funct. 1, 149-155. doi: 10.1039/c0fo00080a.
17. Harmsen, H. J., Wildeboer-Veloo, A. C., Grijpstra, J., Knol, J., Degener, J. E., and Welling, G. W. (2000). Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl. Environ. Microbiol. 66, 4523-4527. doi: 10.1128/AEM.66.10.4523-4527.2000.
18. He, M., van Dam, R. M., Rimm, E., Hu, F. B., and Qi, L. (2010). Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation 121, 2162-2168. doi: 10.1161/CIRCULATIONAHA.109.907360.
19. Hughes, S. A., Shewry, P. R., Gibson, G. R., McCleary, B. V., and Rastall, R. A. (2008). In vitro fermentation of oat and barley derived beta-glucans by human fecal microbiota. FEMS Microbiol. Ecol. 64, 482-493. doi: 10.1111/j.1574-6941.2008.00478.x.
20. Jacobs, D. R., Meyer, K. A., Kushi, L. H., and Folsom, A. R. (1999). Is whole grain intake associated with reduced total and cause-specific death rates in older women? The Iowa Women's Health Study. Am. J. Public Health. 89, 322-329. doi: 10.2105/AJPH.89.3.322.
21. Jones, M. L., Martoni, C. J., Parent, M., and Prakash, S. (2012a). Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br. J. Nutr. 107, 1505-1513. doi: 10.1017/S0007114511004703.
22. Jones, M. L., Martoni, C. J., and Prakash, S. (2012b). Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur. J. Clin. Nutr. 66, 1234-1241. doi: 10.1038/ejcn.2012.126.
23. Kim, G. B., Yi, S. H., and Lee, B. H. (2004). Purification and characterization of three different types of bile salt hydrolases from Bifidobacterium strains. J. Dairy Sci. 87, 258-266. doi: 10.3168/jds.S0022-0302(04)73164-1.
24. Kim, H. J., and White, P. J. (2009). In vitro fermentation of oat flours from typical and high beta-glucan oat lines. J. Agric. Food Chem. 57, 7529-7536. doi: 10.1021/jf900788c.
25. Langendijk, P. S., Schut, F., Jansen, G. J., Raangs, G. C., Kamphuis, G. R., Wilkinson, M. H., et al. (1995). Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl. Environ. Microbiol. 61, 3069-3075.
26. Levrat, M. A., Favier, M. L., Moundras, C., Rémésy, C., Demigné, C., and Morand, C. (1994). Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats. J. Nutr. 124, 531-538.
27. Manz, W., Amann, R., Ludwig, W., Vancanneyt, M., and Schleifer, K. H. (1996). Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 1097-1106. doi: 10.1099/13500872-142-5-1097.
28. Mellen, P. B., Walsh, T. F., and Herrington, D. M. (2008). Whole grain intake and cardiovascular disease: a meta-analysis. Nutr. Metab. Cardiovasc. Dis. 18, 283-290. doi: 10.1016/j.numecd.2006.12.008.
29. Mensink, R. P., Zock, P. L., Kester, A. D., and Katan, M. B. (2003). Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77, 1146-1155.
30. Montonen, J., Knekt, P., Järvinen, R., Aromaa, A., and Reunanen, A. (2003). Whole-grain and fiber intake and the incidence of type 2 diabetes. Am. J. Clin. Nutr. 77, 622-629.
31. Nilsson, U., Johansson, M., Nilsson, A., Björck, I., and Nyman, M. (2008). Dietary supplementation with beta-glucan enriched oat bran increases fecal concentration of carboxylic acids in healthy subjects. Eur. J. Clin. Nutr. 62, 978-984. doi: 10.1038/sj.ejcn.1602816.
32. Nordlund, E., Aura, A. M., Mattila, I., Kössö, T., Rouau, X., and Poutanen, K. (2012). Formation of phenolic microbial metabolites and short-chain fatty acids from rye, wheat, and oat bran and their fractions in the metabolical in vitro colon model. J. Agric. Food Chem. 60, 8134-8145. doi: 10.1021/jf3008037.
33. Ooi, L. G., Ahmad, R., Yuen, K. H., and Liong, M. T. (2010). Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J. Dairy Sci. 93, 5048-5058. doi: 10.3168/jds.2010-3311.
34. Park, O. J., Kang, N. E., Chang, M. J., and Kim, W. K. (2004). Resistant starch supplementation influences blood lipid concentrations and glucose control in overweight subjects. J. Nutr. Sci. Vitaminol. 50, 93-99. doi: 10.3177/jnsv.50.93.
35. Queenan, K. M., Stewart, M. L., Smith, K. N., Thomas, W., Fulcher, R. G., and Slavin, J. L. (2007). Concentrated oat beta-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr. J. 6, 6-6. doi: 10.1186/1475-2891-6-6.
36. Ripsin, C. M., Keenan, J. M., Jacobs, D. R., Elmer, P. J., Welch, R. R., Van Horn, L., et al. (1992). Oat products and lipid lowering. A meta-analysis. JAMA 267, 3317-3325. doi: 10.1001/jama.1992.03480240079039.
37. Ryan, D., Kendall, M., and Robards, K. (2007). Bioactivity of oats as it relates to cardiovascular disease. Nutr. Res. Rev. 20, 147-162. doi: 10.1017/S0954422407782884.
38. Rycroft, C. E., Jones, M. R., Gibson, G. R., and Rastall, R. A. (2001). A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J. Appl. Microbiol. 91, 878-887. doi: 10.1046/j.1365-2672.2001.01446.x.
39. Shapiro, D. J., and Rodwell, V. W. (1971). Regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis. J. Biol. Chem. 246, 3210-3216.
40. Sheu, W. H.-H., Lee, I. T., Chen, W., and Chan, Y.-C. (2008). Effects of xylooligosaccharides in type 2 diabetes mellitus. J. Nutr. Sci. Vitaminol. 54, 396-401. doi: 10.3177/jnsv.54.396.
41. Tanaka, H., Doesburg, K., Iwasaki, T., and Mierau, I. (1999). Screening of lactic acid bacteria for bile salt hydrolase activity. J. Dairy Sci. 82, 2530-2535. doi: 10.3168/jds.S0022-0302(99)75506-2.
42. Tiwari, U., and Cummins, E. (2011). Meta-analysis of the effect of β-glucanaintake on blood cholesterol and glucose levels. Nutrition 27, 1008-1016. doi: 10.1016/j.nut.2010.11.006.
43. Turunen, K., Tsouvelakidou, E., Nomikos, T., Mountzouris, K. C., Karamanolis, D., Triantafillidis, J., et al. (2011). Impact of beta-glucan on the fecal microbiota of polypectomized patients: a pilot study. Anaerobe 17, 403-406. doi: 10.1016/j.anaerobe.2011.03.025.
44. Vulevic, J., Juric, A., Tzortzis, G., and Gibson, G. R. (2013). A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 143, 324-331. doi: 10.3945/jn.112.166132.
45. Wolever, T. M., Gibbs, A. L., Brand-Miller, J., Duncan, A. M., Hart, V., Lamarche, B., et al. (2011). Bioactive oat β-glucan reduces LDL cholesterol in Caucasians and non-Caucasians. Nutr. J. 10,130. doi: 10.1186/1475-2891-10-130.
46. Ye, E. Q., Chacko, S. A., Chou, E. L., Kugizaki, M., and Liu, S. (2012). Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J. Nutr. 142, 1304-1313. doi: 10.3945/jn.111.155325.
47. Zhang, J., Li, L., Song, P., Wang, C., Man, Q., Meng, L., et al. (2012). Randomized controlled trial of oatmeal consumption versus noodle consumption on blood lipids of urban Chinese adults with hypercholesterolemia. Nutr. J. 11:54. doi: 10.1186/1475-2891-11-54.